These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28508087)

  • 1. The Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC) trial: Rationale and design of a multi-center, double-blind, placebo-controlled trial of high dose bolus administration of vitamin D3 during acute pulmonary exacerbation of cystic fibrosis.
    Tangpricha V; Smith EM; Binongo J; Judd SE; Ziegler TR; Walker S; Tirouvanziam R; Zughaier SM; Lee MJ; Chesdachai S; Hermes WA; Chmiel JF; Gaggar A; Grossmann RE; Joseph PM; Alvarez JA
    Contemp Clin Trials Commun; 2017 Jun; 6():39-45. PubMed ID: 28508087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D for the Immune System in Cystic Fibrosis (DISC): a double-blind, multicenter, randomized, placebo-controlled clinical trial.
    Tangpricha V; Lukemire J; Chen Y; Binongo JNG; Judd SE; Michalski ES; Lee MJ; Walker S; Ziegler TR; Tirouvanziam R; Zughaier SM; Chesdachai S; Hermes WA; Chmiel JF; Grossmann RE; Gaggar A; Joseph PM; Alvarez JA
    Am J Clin Nutr; 2019 Mar; 109(3):544-553. PubMed ID: 30793177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D for glycemic control following an acute pulmonary exacerbation: A secondary analysis of a multicenter, double-blind, randomized, placebo-controlled trial in adults with cystic fibrosis.
    Sivapiromrat AK; Hunt WR; Alvarez JA; Ziegler TR; Tangpricha V
    medRxiv; 2024 Mar; ():. PubMed ID: 38343807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
    Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
    Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D
    Alvarez JA; Chong EY; Walker DI; Chandler JD; Michalski ES; Grossmann RE; Uppal K; Li S; Frediani JK; Tirouvanziam R; Tran VT; Tangpricha V; Jones DP; Ziegler TR
    Metabolism; 2017 May; 70():31-41. PubMed ID: 28403943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: A randomized, controlled trial.
    Grossmann RE; Zughaier SM; Kumari M; Seydafkan S; Lyles RH; Liu S; Sueblinvong V; Schechter MS; Stecenko AA; Ziegler TR; Tangpricha V
    Dermatoendocrinol; 2012 Apr; 4(2):191-7. PubMed ID: 22928076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Contributing to Vitamin D Status at Hospital Admission for Pulmonary Exacerbation in Adults With Cystic Fibrosis.
    Bhimavarapu A; Deng Q; Bean M; Lee N; Ziegler TR; Alvarez J; Tangpricha V
    Am J Med Sci; 2021 Jan; 361(1):75-82. PubMed ID: 32988598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 × 2 trial of administration of prebiotics and cholecalciferol (vitamin D
    Sivapiromrat AK; Suppakitjanusant P; Wang Y; Binongo J; Hunt WR; Gewirtz A; Alvarez JA; Hu C; Weinstein S; Jathal I; Ziegler TR; Tangpricha V
    medRxiv; 2024 Jan; ():. PubMed ID: 38343811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulised hypertonic saline for cystic fibrosis.
    Wark P; McDonald VM
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001506. PubMed ID: 30260472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D
    Sivapiromrat AK; Suppakitjanusant P; Wang Y; Hu C; Binongo J; Hunt WR; Weinstein S; Jathal I; Alvarez JA; Chassaing B; Ziegler TR; Gewirtz AT; Tangpricha V
    Contemp Clin Trials Commun; 2024 Apr; 38():101278. PubMed ID: 38435430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D for the management of asthma.
    Williamson A; Martineau AR; Sheikh A; Jolliffe D; Griffiths CJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD011511. PubMed ID: 36744416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant supplementation for lung disease in cystic fibrosis.
    Ciofu O; Smith S; Lykkesfeldt J
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD007020. PubMed ID: 31580490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial.
    Valery PC; Morris PS; Grimwood K; Torzillo PJ; Byrnes CA; Masters IB; Bauert PA; McCallum GB; Mobberly C; Chang AB
    BMC Pediatr; 2012 Aug; 12():122. PubMed ID: 22891748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EMPIRE-CF: A phase II randomized placebo-controlled trial of once-daily, oral acebilustat in adult patients with cystic fibrosis - Study design and patient demographics.
    Elborn JS; Ahuja S; Springman E; Mershon J; Grosswald R; Rowe SM
    Contemp Clin Trials; 2018 Sep; 72():86-94. PubMed ID: 30056216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bolus Weekly Vitamin D3 Supplementation Impacts Gut and Airway Microbiota in Adults With Cystic Fibrosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.
    Kanhere M; He J; Chassaing B; Ziegler TR; Alvarez JA; Ivie EA; Hao L; Hanfelt J; Gewirtz AT; Tangpricha V
    J Clin Endocrinol Metab; 2018 Feb; 103(2):564-574. PubMed ID: 29161417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
    Skilton M; Krishan A; Patel S; Sinha IP; Southern KW
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009841. PubMed ID: 30616300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children With Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial.
    Forno E; Bacharier LB; Phipatanakul W; Guilbert TW; Cabana MD; Ross K; Covar R; Gern JE; Rosser FJ; Blatter J; Durrani S; Han YY; Wisniewski SR; Celedón JC
    JAMA; 2020 Aug; 324(8):752-760. PubMed ID: 32840597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.